Peter Hunkus
Family · Youngstown, OHNPI 1780297945
Payments from drug & device makers
Across 168 payments — averaging $17.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$890
- Novo Nordisk$266
- AstraZeneca$254
- Pfizer$172
- GSK$170
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$152
- plus $1K from 26 others
What the payments were for
- Food & beverage$2,916100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $890 |
| Novo Nordisk | 18 | $266 |
| AstraZeneca | 16 | $254 |
| Pfizer | 9 | $172 |
| GSK | 12 | $170 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $152 |
| Lilly USA, LLC | 8 | $146 |
| Johnson & Johnson | 8 | $126 |
| Boehringer Ingelheim | 8 | $121 |
| Novartis | 5 | $74 |
| Collegium Pharmaceutical, Inc. | 4 | $53 |
| Xeris Pharmaceuticals, Inc. | 3 | $52 |
| Amgen(2 entities) | 2 | $38 |
| E.r. Squibb & Sons, L.L.C. | 2 | $37 |
| Exact Sciences | 2 | $35 |
| Amarin Pharma, Inc. | 2 | $35 |
| Astellas Pharma US Inc | 1 | $29 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| GRT US Holding, Inc. | 1 | $17 |
| Merck | 1 | $17 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Qiagen, LLC | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Almatica Pharma LLC | 1 | $14 |
| Redhill Biopharma Inc. | 1 | $12 |
How this compares
$2,916 in reported general payments places this provider in the 85th percentile of 6,812 family providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 62 | $50,537 |
| XareltoRivaroxaban | 67 | $46,769 |
| JardianceEmpagliflozin | 28 | $25,829 |
| OzempicSemaglutide | 23 | $22,335 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 27 | $21,699 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 28 | $17,157 |
| JanuviaSitagliptin Phosphate | 13 | $15,443 |
| Breo ElliptaFluticasone/Vilanterol | 12 | $5,612 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $5,175 |
| Novolin NInsulin Nph Human Isophane | 11 | $1,997 |
| SynthroidLevothyroxine Sodium | 23 | $1,766 |
| Atorvastatin Calcium | 239 | $1,723 |
| Midodrine Hcl | 11 | $1,488 |
| Metoprolol Succinate | 111 | $1,481 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $1,408 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $172 | $50,53762 claims |
| Johnson & JohnsonXarelto | $126 | $46,76967 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta | $170 | $32,48651 claims |
| Boehringer IngelheimJardiance | $121 | $25,82928 claims |
| Novo NordiskOzempic | $266 | $22,33523 claims |
| AstraZenecaBreztri Aerosphere | $254 | $17,15728 claims |
| MerckJanuvia | $17 | $15,44313 claims |
| AbbVieSynthroid | $890 | $1,76623 claims |
| Almatica Pharma LLCSertraline Hcl | $14 | $490111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,812 family providers in Ohio.
Other family in Youngstown
- Andrea SvobodaYoungstown$91K
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.